3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
3
Neuroblastoma
3
Melanoma
3
Lung Neoplasms
3
Ganglioneuroblastoma
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Transplant-Related Hematologic Malignancy
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Prostatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Plasma Cell
1
Leukemia
1
Hodgkin Disease
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Merkel Cell
1
Carcinoma, Hepatocellular
1
Adenoma, Islet Cell
1
Interventions
Magnetic Resonance Spectroscopy
3
selpercatinib
2
entrectinib
2
Specimen Handling
2
Interviews as Topic
2
tremelimumab
1
trametinib
1
omipalisib
1
gallium Ga 68 dotatate
1
durvalumab
1
cabozantinib
1
X-Rays
1
Vemurafenib
1
Transurethral Resection of Prostate
1
Surveys and Questionnaires
1
Sodium Iodide
1
Postoperative Period
1
Phantoms, Imaging
1
Nivolumab
1
Ipilimumab
1
Iodine-131
1
Iodine-124
1
Decision Support Techniques
1
Counseling
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Cancer, Papillary
×
sargramostim
×
90 days
×
Clear all
No trials found.